CONFIRMED: Antidepressants and other drugs cause dementia

( Natural News ) The largest and most detailed study of its kind has just confirmed that a group of chemical drugs known as anticholinergics, which include antidepressants, antispasmodics, Parkinson’s drugs and bladder control medications, among others, may be directly linked to the development of dementia. The study, which was conducted by researchers from the University of East Anglia in the United Kingdom, found that long-term use of these drugs is strongly linked to the onset of dementia, sometimes many years later. (Related: Dementia and Alzheimer’s disease overtake heart disease as the leading cause of death in America .) The devastating effects of dementia The World Health Organization (WHO) explains that dementia is a progressive condition caused by one of several brain illnesses that affect thinking, memory, behavior and the ability to cope with normal everyday activities. Over 47 million people worldwide have been diagnosed with dementia, and that number is expected to rise to over 75 million by 2030, and to triple by 2050. Dementia is a devastating diagnosis for both the patients and their caregivers. In many countries, sufferers are stigmatized, and patients and their families are damaged psychologically, emotionally and economically. Dementia costs the planet around $818 billion each year, and that figure is set to keep escalating. Big Pharma at it again For their study, the East Anglia researchers conducted a sophisticated analysis of over 300,000 medical records which included prescriptions for various medications, including Paxil, Elavil, Zyprexa and Seroquel – antidepressant and bipolar medications. Other drugs which proved to be problematic were medications used for bladder conditions and Parkinson’s disease. Support our mission and protect your health: Organic Seeds of Life combines Red Raspberry Seed Power, Black Cumin Seed Power and Red Grape Seed Powder into the most potent nutrient-rich supplemental superfood powder you’ve […]

Click here to view full article